Principal Securities’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Principal Securities's RMD Position: Q2 2026 in Review
Principal Securities increased its ResMed (RMD) stake by 3.6% in Q2 2026, buying an estimated $8.71K and bringing the position to 1,214 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.
Principal Securities first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $288K in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Principal Securities held 1,214 shares of ResMed worth $237K as of Q2 2026.
- Principal Securities bought 42 ResMed shares in Q2 2026, an estimated $8.71K.
- ResMed made up ﹤0.01% of Principal Securities's portfolio in Q2 2026, its #1445 holding.
- Principal Securities first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
- Principal Securities's ResMed position peaked at $288K in Q2 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.